Development of Mirror-Image VHHs with Less Immunogenicity

This book outlines the chemical synthesis of therapeutic targets and a screening process for unexplored mirror-image single-domain antibodies (D-VHH). This book first describes the chemical synthesis of model VHH and the characteristics of both enantiomeric VHHs, including binding activity, biodistr...

詳細記述

保存先:
書誌詳細
第一著者: Aoki, Keisuke (著者)
団体著者: SpringerLink (Online service)
フォーマット: 電子媒体 eBook
言語:英語
出版事項: Singapore : Springer Nature Singapore : Imprint: Springer, 2025.
版:1st ed. 2025.
シリーズ:Springer Theses, Recognizing Outstanding Ph.D. Research,
主題:
オンライン・アクセス:https://doi.org/10.1007/978-981-96-1301-4
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

MARC

LEADER 00000nam a22000005i 4500
001 978-981-96-1301-4
003 DE-He213
005 20260706120913.0
007 cr nn 008mamaa
008 250114s2025 si | s |||| 0|eng d
020 |a 9789819613014  |9 978-981-96-1301-4 
024 7 |a 10.1007/978-981-96-1301-4  |2 doi 
050 4 |a QD1-999 
072 7 |a PN  |2 bicssc 
072 7 |a SCI013000  |2 bisacsh 
072 7 |a PN  |2 thema 
082 0 4 |a 541.39  |2 23 
100 1 |a Aoki, Keisuke.  |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
245 1 0 |a Development of Mirror-Image VHHs with Less Immunogenicity  |h [electronic resource] /  |c by Keisuke Aoki. 
250 |a 1st ed. 2025. 
264 1 |a Singapore :  |b Springer Nature Singapore :  |b Imprint: Springer,  |c 2025. 
300 |a XI, 116 p. 56 illus., 36 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
341 0 |b Table of contents navigation  |2 onix 
341 0 |b Single logical reading order  |2 onix 
341 0 |b Short alternative textual descriptions  |2 onix 
341 0 |b Use of color is not sole means of conveying information  |2 onix 
341 0 |b Use of high contrast between text and background color  |2 onix 
341 0 |b Next / Previous structural navigation  |2 onix 
341 0 |b All non-decorative content supports reading without sight  |2 onix 
347 |a text file  |b PDF  |2 rda 
490 1 |a Springer Theses, Recognizing Outstanding Ph.D. Research,  |x 2190-5061 
505 0 |a Chapter 1.Introduction -- Chapter 2.Chemical Synthesis of Mirror-Image VHHs and Evaluation of Their Immunogenicity -- Chapter 3.Identification of a Mirror-Image VHH against Vascular Endothelial Growth Factor -- Chapter 4.Synthetic Study of Full-Length Hepatitis B Virus Core Protein and Its Capsid Assembly -- Chapter 5.Chemical Synthesis of Interleukin-6 for Mirror-Image VHH Discovery -- Chapter 6.Conclusions. 
520 |a This book outlines the chemical synthesis of therapeutic targets and a screening process for unexplored mirror-image single-domain antibodies (D-VHH). This book first describes the chemical synthesis of model VHH and the characteristics of both enantiomeric VHHs, including binding activity, biodistribution and immunogenicity. Immunogenicity testing in mice demonstrated that administration of conventional L-VHH induced the generation of anti-drug antibodies while D-VHH-binding antibodies were not observed in D-VHH-immunized mice. Second, it is explained that the T7-phage-based mirror-image screening system was developed to identify D-VHH antibody fragments capable of binding to vascular endothelial growth factors. Additionally, this book details the chemical synthesis of full-length hepatitis B virus core protein and interleukin-6 for the application of exploring D-VHHs and other mirror-image molecules. Demonstrating that it is possible to develop a D-VHH that preferentially binds the native target protein and exhibits reduced immunogenicity, this book is useful for anyone interested in developing alternative biotherapeutics with reduced immunogenicity by combining chemical and biological approaches. 
532 8 |a Accessibility summary: This PDF does not fully comply with PDF/UA standards, but does feature limited screen reader support, described non-text content (images, graphs), bookmarks for easy navigation and searchable, selectable text. Users of assistive technologies may experience difficulty navigating or interpreting content in this document. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com. 
532 8 |a No reading system accessibility options actively disabled 
532 8 |a Publisher contact for further accessibility information: accessibilitysupport@springernature.com 
650 0 |a Chemistry. 
650 0 |a Pharmacy. 
650 0 |a Proteins. 
650 0 |a Immunogenetics. 
650 1 4 |a Chemical Synthesis. 
650 2 4 |a Pharmacy. 
650 2 4 |a Proteins. 
650 2 4 |a Immunogenetics. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9789819613007 
776 0 8 |i Printed edition:  |z 9789819613021 
776 0 8 |i Printed edition:  |z 9789819613038 
830 0 |a Springer Theses, Recognizing Outstanding Ph.D. Research,  |x 2190-5061 
856 4 0 |u https://doi.org/10.1007/978-981-96-1301-4 
912 |a ZDB-2-CMS 
912 |a ZDB-2-SXC 
912 |a ZDB-2-249 
950 |a Chemistry and Materials Science (SpringerNature-11644) 
950 |a Chemistry and Material Science (R0) (SpringerNature-43709) 
950 |a Focus Bundle Chemistry and Materials Science (SpringerNature-85419)